Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Express Scripts
Mallinckrodt
Moodys
Dow

Last Updated: May 19, 2022

Details for New Drug Application (NDA): 018482


✉ Email this page to a colleague

« Back to Dashboard

NDA 018482 describes PROCARDIA, which is a drug marketed by Pfizer and is included in two NDAs. It is available from one supplier. Additional details are available on the PROCARDIA profile page.

The generic ingredient in PROCARDIA is nifedipine. There are thirty-nine drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the nifedipine profile page.
Summary for 018482
Tradename:PROCARDIA
Applicant:Pfizer
Ingredient:nifedipine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018482
Suppliers and Packaging for NDA: 018482
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROCARDIA nifedipine CAPSULE;ORAL 018482 NDA AUTHORIZED GENERIC Greenstone LLC 59762-1004 59762-1004-1 100 CAPSULE in 1 BOTTLE (59762-1004-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength20MG
Approval Date:Jul 24, 1986TE:RLD:Yes

Expired US Patents for NDA 018482

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer PROCARDIA nifedipine CAPSULE;ORAL 018482-002 Jul 24, 1986 See Plans and Pricing See Plans and Pricing
Pfizer PROCARDIA nifedipine CAPSULE;ORAL 018482-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Pfizer PROCARDIA nifedipine CAPSULE;ORAL 018482-002 Jul 24, 1986 See Plans and Pricing See Plans and Pricing
Pfizer PROCARDIA nifedipine CAPSULE;ORAL 018482-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Baxter
Merck
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.